이동호 (서울대학교병원)님 | 한빛사연구자 > 한빛사

서울대학교병원

CV File

응용의학

최종업데이트 2022.09.28.

Adverse Event Monitoring with Imaging: Prognostic Significance in Atezolizumab Plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma
- Liver Cancer, October 09 2025 | https://doi.org/10.1159/000548830
- 2025-10
- 의약학
- 한빛사논문
Non-contrast MRI for Detection of Late Recurrent Hepatocellular Carcinoma After Curative Treatment: A Prospective Multicenter Comparison to Contrast-enhanced CT
- Clin. Mol. Hepatol., Jun 13 2025, | https://doi.org/10.3350/cmh.2025.0258
- 2025-06
- 의약학
- 한빛사논문
Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score
- Radiology, 2023 Jun;307(5):e222106 | https://doi.org/10.1148/radiol.222106
- 2023-06
- 의약학
- 한빛사논문
Two-dimensional Shear-Wave Elastography and US Attenuation Imaging for Nonalcoholic Steatohepatitis Diagnosis: A Cross-sectional, Multicenter Study
- Radiology, Published Online:Jun 21 2022 | https://doi.org/10.1148/radiol.220220
- 2022-06
- 의약학
- 한빛사논문
Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial
- Radiology, Published Online:Jul 27 2021 | https://doi.org/10.1148/radiol.2021210309
- 2021-07
- 의약학
- 한빛사논문
Radiofrequency Ablation of Hepatocellular Carcinoma as First-Line Treatment: Long-term Results and Prognostic Factors in 162 Patients with Cirrhosis
- Radiology, Volume 270, Issue 3, March 2014, Pages 900-909 | https://doi.org/10.1148/radiol.13130940
- 2014-03
- 의약학
- 상위피인용논문
Non-hypervascular Hepatobiliary phase Hypointense Nodules on Gadoxetic Acid-enhanced MRI: Risk of HCC Recurrence after Radiofrequency Ablation
- J. Hepatol., Available online 18 December 2014 | doi:10.1016/j.jhep.2014.12.015
- 2014-12
- 의약학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기